These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10083588)

  • 1. The cost-effectiveness of transplantation with expanded donor kidneys.
    Whiting JF; Zavala EY; Alexander JW; First MR
    Transplant Proc; 1999; 31(1-2):1320-1. PubMed ID: 10083588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation.
    Snyder RA; Moore DR; Moore DE
    Clin Transplant; 2013; 27(2):289-96. PubMed ID: 23350938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model.
    Douzdjian V; Ferrara D; Silvestri G
    Am J Kidney Dis; 1998 May; 31(5):794-802. PubMed ID: 9590189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic aspects of renal transplantation.
    Kaló Z
    Transplant Proc; 2003 May; 35(3):1223-6. PubMed ID: 12947912
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.
    Whiting JF; Woodward RS; Zavala EY; Cohen DS; Martin JE; Singer GG; Lowell JA; First MR; Brennan DC; Schnitzler MA
    Transplantation; 2000 Sep; 70(5):755-60. PubMed ID: 11003352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplantation vs hemodialysis: cost-effectiveness analysis.
    Perović S; Janković S
    Vojnosanit Pregl; 2009 Aug; 66(8):639-44. PubMed ID: 19780419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of kidney transplantation from DCD in Italy.
    Cavallo MC; Sepe V; Conte F; Abelli M; Ticozzelli E; Bottazzi A; Geraci PM
    Transplant Proc; 2014 Dec; 46(10):3289-96. PubMed ID: 25498039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of the various replacement therapies for chronic renal failure: haemodialysis and renal transplantation].
    Altieri P; Piredda G; Murgia MG; Onano B; Meloni F
    G Ital Nefrol; 2004; 21 Suppl 26():S3-9. PubMed ID: 15732042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment costs between dialysis and transplantation.
    Eggers P
    Semin Nephrol; 1992 May; 12(3):284-9. PubMed ID: 1615249
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness analysis of alternative treatments of end-stage renal disease: Philippine experience.
    Naidas OD; Chan-Licuanan KR; Velasco VP; Dalay CV; Bayog DV; Rosete-Liquete RM
    Transplant Proc; 1998 Nov; 30(7):3116. PubMed ID: 9838375
    [No Abstract]   [Full Text] [Related]  

  • 14. A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation.
    Simon DG
    Med Decis Making; 1986; 6(4):199-207. PubMed ID: 3095605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis strategy: cost and effectiveness.
    Kerr DN
    Proc Eur Dial Transplant Assoc; 1981; 18():664-73. PubMed ID: 6799954
    [No Abstract]   [Full Text] [Related]  

  • 16. The economics of kidney transplantation versus hemodialysis.
    Loubeau PR; Loubeau JM; Jantzen R
    Prog Transplant; 2001 Dec; 11(4):291-7. PubMed ID: 11871278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.
    Wong G; Howard K; Chapman JR; Chadban S; Cross N; Tong A; Webster AC; Craig JC
    PLoS One; 2012; 7(1):e29591. PubMed ID: 22279541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
    Lewis RL; Canafax DM; Pettit KG; DiCesare J; Kaniecki DJ; Arnold RJ; Roberts MS
    Transplant Proc; 1996 Aug; 28(4):2214-7. PubMed ID: 8769203
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.
    Sesso R; Eisenberg JM; Stabile C; Draibe S; Ajzen H; Ramos O
    Int J Technol Assess Health Care; 1990; 6(1):107-14. PubMed ID: 2113888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit estimation of cadaveric kidney transplantation: the case of a developing country.
    Domínguez J; Harrison R; Atal R
    Transplant Proc; 2011; 43(6):2300-4. PubMed ID: 21839259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.